(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIOPHARM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BIOPHARM

ST13

US500000077334324

Class

5

Filing

77334324

Registration

3467067

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

07/24/2018

Trademark type

Combined

Nice classes

5

Filing date

11/20/2007

Registration date

07/15/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/24/2018

Last transaction

07/24/2018

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

1995-01-00

First use in commerce

1995-01-00

Drawing code

3

Owner type

03

Owner location

Herndon, VA

Examiner

WELLS, CHRISTOPHER

Law office

L60

Current location

GENERIC WEB UPDATE

Mark description

"The mark consists of a horizontal line with the text "BIOPHARM" underneath it and a design comprised of three leaves above it, wherein the color green appears in the leaf design, the color black appears in the horizontal lines and printed terms and the color white appears in the background."

Holders and representatives

Holders

Biopharm R&D Corporation Limited
Biopharm R&D Corporation Limited

Representatives

BIOPHARM R&D CORPORATION LIMITED

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Nutraceuticals for use dietary supplements; Pharmaceutical and nutraceutical productsanalgesicsanti-inflammatory agentsantibiotic preparationsantifungal preparationsantiviral preparationsantitussive preparations in the form of elixirsfluid and solid extractsointmentspillssolutionssyrupstabletstincturesglobules and waters; pharmaceutical and nutraceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; pharmaceutical and nutraceutical preparations for use in the treatment of woundsskin disordersallergic disordersinflammatory disorders; pharmaceutical and nutraceutical preparations for use in dermatologyurologygynecology

Publications

History of USPTO decisions and trademark events.

28 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/24/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/24/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/24/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/24/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

07/11/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/11/2018

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/15/2017

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/03/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/03/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/03/2014

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

05/16/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/16/2014

E815

TEAS SECTION 8 & 15 RECEIVED

05/16/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

07/15/2008

PUBO

PUBLISHED FOR OPPOSITION

04/29/2008

NPUB

NOTICE OF PUBLICATION

04/09/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/24/2008

ALIE

ASSIGNED TO LIE

03/24/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/07/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/06/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/06/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/06/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/04/2008

GNRT

NON-FINAL ACTION E-MAILED

03/04/2008

CNRT

NON-FINAL ACTION WRITTEN

03/04/2008

DOCK

ASSIGNED TO EXAMINER

03/04/2008

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

11/27/2007

NWAP

NEW APPLICATION ENTERED

11/26/2007

Continuous trademark protection

Get notified about every new filing that threatens BIOPHARM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.